Lonza names Celonic CEO Samanta Cimitan as first chief commercial officer; WuXi Bio, WuXi XDC post H1 revenue growth; Prestige recalls Clear Eyes drops.
August 27, 2026 10:31 AM EDT
Manufacturing
Lonza creates commercial chief position; WuXi Biologics reports revenue jump
Anna Brown
News Reporter
CDMO Lonza is strengthening its market leadership with a newly created role that puts seasoned exec Samanta Cimitan, Ph.D., at…
Lonza said it wants to own the commercial market for antibody-drug conjugates, with a new manufacturing site set to come online…
WuXi AppTec surpassed Lonza in H1 2026 revenue ($4.28B vs $4.17B), despite Pentagon scrutiny.
Contract manufacturing powerhouse Lonza is growing in more ways than one. | Contract manufacturing powerhouse Lonza is growing in…
WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer…
Silvia Luque announced on LinkedIn that she was named head of US marketing at Zealand Pharma. She had been executive director of…
